What is Ventricular Tachycardia?
Ventricular tachycardia, also called V-tach or VT, is a fast, abnormal heart rhythm (arrhythmia) that originates in the ventricles (the lower chambers of the heart). It is characterized by a heart rate of 100 beats per minute or more and can be life-threatening if sustained or if it deteriorates into ventricular fibrillation, leading to cardiac arrest.
Causes of Ventricular Tachycardia
VT often occurs in people with underlying heart disease, but it can also affect those without structural heart problems. Common causes include:
- Heart disease: Coronary artery disease, previous heart attack, cardiomyopathy
- Electrolyte imbalances: Low potassium or magnesium
- Congenital conditions: Long QT syndrome, Brugada syndrome
- Structural heart issues: Heart failure, valve disease
- Medication side effects: Antiarrhythmic drugs, stimulants
- Substance use: Cocaine, methamphetamine, excessive alcohol or caffeine
Symptoms of Ventricular Tachycardia
Symptoms depend on heart function and VT duration, ranging from mild to severe:
- Palpitations (rapid heartbeats)
- Dizziness or lightheadedness
- Shortness of breath
- Chest pain or discomfort
- Syncope (fainting)
- Cardiac arrest
In some instances, there are no symptoms at all.
Diagnosis of Ventricular Tachycardia
Ventricular Tachycardia (VT) is diagnosed using the following methods:
- Electrocardiogram (ECG/EKG) – The primary test that detects abnormal ventricular rhythms, showing wide QRS complexes (>120 ms) and a fast heart rate (>100 bpm).
- Holter Monitor – A portable ECG device worn for 24-48 hours to capture intermittent VT episodes.
- Event Monitor – A longer-term wearable device that records heart activity when symptoms occur.
- Electrophysiology (EP) Study – A specialized procedure where electrodes are placed inside the heart to map and trigger arrhythmias.
- Echocardiogram & Cardiac MRI – Used to assess structural heart disease that may contribute to VT.
- Blood Tests – To check for electrolyte imbalances (e.g., potassium, magnesium) or markers of heart disease.
Treatment for Ventricular Tachycardia
The treatment for ventricular tachycardia depends on its severity, underlying cause, and whether the patient is stable or unstable. For unstable VT (e.g., symptoms like hypotension, syncope, or cardiac arrest), immediate treatment involves electrical cardioversion, where an electric shock is used to restore a normal heart rhythm. Medications such as amiodarone or lidocaine may also be administered intravenously to stabilize the rhythm. In cases of sustained VT, especially in high-risk patients, an Implantable Cardioverter-Defibrillator (ICD) is often recommended to prevent sudden cardiac death by delivering shocks if the VT recurs. For patients with structural heart disease or VT caused by scarring (e.g., post-myocardial infarction), catheter ablation may be considered to target and destroy abnormal electrical pathways. Beta-blockers and other antiarrhythmic medications, such as sotalol, may also be prescribed to prevent recurrent episodes of VT. In cases where VT is caused by electrolyte imbalances or drug toxicity, correcting these factors is essential to help reduce the risk of future arrhythmias.